Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
  1. 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
  2. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,703 shares (grant or award)
  3. 4 Planned sale CHIEF FINANCIAL OFFICER sold 75,000 shares at $11.78 ($883,500)
  4. 4 Planned sale Former Director sold 10,000 shares at $9.58 ($95,800)
  5. 4 Grant or award Chief Medical Officer acquired 168 shares (grant or award)
  6. 4 Grant or award Chief Commercial Officer acquired 168 shares (grant or award)
  7. 4 Grant or award Chief Strategy Officer acquired 156 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
  9. 4 Grant or award Former Director acquired 2,778 shares (grant or award)
  10. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,703 shares (grant or award)
  11. 4 Planned sale Former Director sold 9,599 shares at $10.41 ($99,926)
  12. 4 Grant or award Chief Commercial Officer acquired 168 shares (grant or award)
  13. 4 Grant or award Chief Medical Officer acquired 168 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 1,159 shares (grant or award)
  15. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 1,703 shares (grant or award)
  16. 4 Grant or award Chief Strategy Officer acquired 156 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 18 · 349 filings